Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
BioNTech SE - American Depositary Shares
(NQ:
BNTX
)
90.58
-2.27 (-2.44%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 31, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about BioNTech SE - American Depositary Shares
< Previous
1
2
...
25
26
27
28
29
30
31
32
33
...
72
73
Next >
Pfizer, BioNTech Take Next Step Toward A Pan-Covid Vaccine — But Is The Demand There?
↗
November 17, 2022
The biggest question facing the shot is whether there will be demand for it.
Via
Investor's Business Daily
Ukraine Asserts It Does Not Take Blame For Poland Missile Attack, Crypto Exchange Gemini Suffers $485M In Outflows, FTX, Bahamas Regulator Lock Horns Over Control Of Bankruptcy Proceedings: Top Stories Thursday, Nov. 17
↗
November 17, 2022
CNBC
Via
Benzinga
Pfizer, BioNTech Start Work On Next-Gen COVID-19 Vaccine Candidate For Broader Protection
↗
November 17, 2022
Via
Benzinga
Pfizer and BioNTech Advance Next-Generation COVID-19 Vaccine Strategy with Study Start of Candidate Aimed at Enhancing Breadth of T cell Responses and Duration of Protection
November 16, 2022
From
BioNTech SE
Via
GlobeNewswire
This COVID-19 Vaccine Stock Has More to Offer
↗
November 10, 2022
The vaccine revenue was nice, but it's time to look ahead.
Via
The Motley Fool
While COVID-19 Drags On, Biotechs Introduce New Treatments & Vaccines to Combat Subvariants
November 16, 2022
EQNX::TICKER_START (OTCQB:BIXT),(NASDAQ:NVAX),(NYSE:PFE),(NASDAQ:MRNA),(NASDAQ:INO),(NASDAQ:BNTX) EQNX::TICKER_END
Via
FinancialNewsMedia
Third COVID-19 Booster or Fifth Dose Not Required Despite Surge In Cases, Australian Health Authorities Say
↗
November 15, 2022
Australian health authorities have recommended against a fifth COVID-19 vaccine shot despite average daily cases having been 47% higher last week than the week before, said Health Minister Mark Butler...
Via
Benzinga
Moderna Surges On New Omicron Data, Pulling Pfizer, BioNTech Along For The Ride
↗
November 14, 2022
Its booster led to a 15.1-fold increase in BA.4- and BA.5-blocking antibodies.
Via
Investor's Business Daily
BioNTech SE (BNTX) Q3 2022 Earnings Call Transcript
↗
November 07, 2022
BNTX earnings call for the period ending September 30, 2022.
Via
The Motley Fool
Biotech Sector Gaining Wins Against Pancreatic Cancer with Early Detection and New Therapies
November 14, 2022
FN Media Group Presents USA News Group News Commentary Vancouver, BC –November 14, 2022 – USA News Group – English actor, comedian and Monty Python alumnus Eric Idle credits early detection for his...
Via
FinancialNewsMedia
BioNTech Plans To Set Up Singapore Based mRNA Plant By End Of 2023
↗
November 14, 2022
Via
Benzinga
BioNTech Expands Global Footprint by Acquiring GMP Manufacturing Site to Establish First mRNA Facility in Singapore
November 13, 2022
From
BioNTech SE
Via
GlobeNewswire
Repeat COVID-19 Infection Increases Risk Of Acute Outcomes, Long COVID Symptoms, Study Shows
↗
November 11, 2022
Via
Benzinga
Is It Time To Pay Attention To This Acellular Biologic Pioneer That Says Its Clinical Trials Are Cheaper And Easier?
November 10, 2022
By Ernest Dela Aglanu, Benzinga
Via
News Direct
Is It Time To Pay Attention To This Acellular Biologic Pioneer That Says Its Clinical Trials Are Cheaper And Easier?
November 10, 2022
Learn more about Organicell Regenerative Medicine, Inc.from this latest report.
Via
TheNewswire.com
Europe Approves Sanofi, GSK's Beta Variant Adapted COVID Shot As Booster
↗
November 10, 2022
Via
Benzinga
Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Vaccine Booster for Children 5 Through 11 Years of Age in European Union
November 10, 2022
From
BioNTech SE
Via
GlobeNewswire
2 Top Healthcare Stocks to Buy Right Now
↗
November 10, 2022
These two dividend stocks offer 3%-plus dividend yields that are secure.
Via
The Motley Fool
Is It Time To Pay Attention To This Acellular Biologic Pioneer That Says Its Clinical Trials Are Cheaper And Easier?
↗
November 10, 2022
During the peak of the deadly COVID-19 pandemic, one novel therapeutic that seems to have played an important role in helping save lives was Organicell Regenerative Medicine Inc.’s (OTCMKTS:...
Via
Benzinga
Return To Office: Pfizer To Enforce 2-3 Days In Office Starting January
↗
November 09, 2022
Pfizer Inc's (NYSE: PFE) CEO Albert Bourla said the U.S. employees would have to return to their workplaces two to three days a week starting in January.
Via
Benzinga
The 7 Best Pharma Stocks to Buy Now
↗
November 08, 2022
Investors searching for gains in the current market storm should consider taking a position in some of the best pharma stocks.
Via
InvestorPlace
Got $2,000? 2 Fantastic Stocks to Buy No Matter What the Market Does Next
↗
November 08, 2022
These stocks both have non-cyclical businesses that can drive growth in a wide variety of markets.
Via
The Motley Fool
BioNTech Takes A Hit Despite Doubling Profit Views, Raising 2022 Outlook
↗
November 07, 2022
BioNTech doubled profit expectations in the third quarter and raised its outlook.
Via
Investor's Business Daily
Meta Goes Twitter Way With Layoffs, Twitter Might Want Some People Back After Firing Them, Coal Miners Terminate $6B Combination Discussions: Top Stories Monday, Nov. 07
↗
November 07, 2022
Wall Street Journal
Via
Benzinga
BioNTech Posts About 50% Drop In Q3 Sales and Profits Amid Falling Demand For COVID-19 Shots
↗
November 07, 2022
Via
Benzinga
Risk Appetites Survive China Keeping Zero COVID Policy
↗
November 07, 2022
Chinese officials denied plans to end the zero-COVID policy and after a brief wobble, risk assets have traded better. Asia Pacific equities rallied, led by Hong Kong and mainland stocks that trade in...
Via
Talk Markets
Recap: BioNTech Q3 Earnings
↗
November 07, 2022
BioNTech (NASDAQ:BNTX) reported its Q3 earnings results on Monday, November 7, 2022 at 06:00 AM. Here's what investors need to know about the announcement. Earnings BioNTech beat estimated earnings by...
Via
Benzinga
BioNTech Announces Third Quarter 2022 Financial Results and Corporate Update
November 07, 2022
From
BioNTech SE
Via
GlobeNewswire
Week in Review: CBC Plans $137 Million Shanghai Biopharma Complex
↗
November 05, 2022
Deals, financings, trials and approvals in Chinese biotech/biopharma this week.
Via
Talk Markets
Did Vaccine Stocks Just Get Their Last Boost?
↗
November 04, 2022
Some positive news sent their share prices higher, but biotech companies will need to find other ways to make money.
Via
The Motley Fool
< Previous
1
2
...
25
26
27
28
29
30
31
32
33
...
72
73
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
